ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Immune Pharmaceuticals Files for Chapter 11 Protection
February 20, 2019Immune Pharmaceuticals has filed for chapter 11 bankruptcy in the Federal Bankruptcy Court in New Jersey.Despite making progress towards a bertilimumab strategic transaction.... -
Bertilimumab Granted Orphan Drug Designation for the Treatment of Bullous Pemphigoid
August 22, 2018Immune Pharmaceuticals, Inc., a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation
Pharma Sources Insight January 2025
